KHDRBS1 and cancer: Similarly, the RAS/ERK pathway modulates a number of splicing factors involved in cancer, such as SAM68 [68] and the alternative splicing factor 45 (SPF45) [69], which in turn affect expression of splice variants that regulate cell motility, proliferation, and survival.